SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: Dauntless who wrote (3322)4/6/1998 9:07:00 AM
From: Hank  Read Replies (1) | Respond to of 7041
 
SGP's statements in their annual report concerning Vasomax (ie that it is a an alternative to Viagra that will hopefully work on those that don't respond to Viagra) validates my hypothesis that SGP already knows Vasomax will not gain immediate approval without first conducting dual clinical trials to compare Vasmoax and Viagra. Approval is a long way away and hardly a sure thing.

Even my barber was asking me about Viagra this weekend. He's in his 60's and has had bypass surgery but doesn't take nitrates anymore. The word has spread pretty fast about this drug already.

Hank



To: Dauntless who wrote (3322)4/6/1998 9:38:00 AM
From: Brander  Read Replies (1) | Respond to of 7041
 
Dauntless, in response to: "I'd like to hear from Brad as to whether the SGP rep introduced Vasomax into their conversation or they were simply having a discussion of available therapies & it "came up" " Vasomax came up in a conversation with two colleagues of mine (both Urologists) about Viagra and the treatment of impotence. One of the Urologists brought up Vasomax, and suggested that from a mechanistic point of view, it would be interesting, and perhaps more effective, to try combining Viagra and Vasomax together. From a physiology point of view, it is a reasonable hypothesis. I might also add, medications used for the same indications are often used in combination for resistant cases. This includes impotence, where currently medications are often used in combinations. As for the question about the SGP rep, I have never run into one.

Brad



To: Dauntless who wrote (3322)4/8/1998 2:03:00 AM
From: Steve H.  Read Replies (1) | Respond to of 7041
 
>> "There's another $47M committed against milestones - and
>> I believe that at least some of those milestones are readily
>> attainable - for instance, the NDA filing, the FDA's acceptance
>> of same, FDA approval, etc."

Great information. What is the source? ZONA's 10K? I'd like to know because I expect there will be movement as their balance sheet changes around these milestones.

What are they exactly? Do you know?